Cervical cytology screening

Obstetrics and Gynecology

Volumn 100, Issue 6, 2002, Pages 1423-1427

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOANALYSIS; CANCER DIAGNOSIS; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DNA DETERMINATION; HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; SAFETY; SAMPLING; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 0036898783     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02632-7     Document Type: Article

References (22)

1. Herrero R. Epidemiology of cervical cancer. J Natl Cancer Inst Monogr 1996;21:1-6.
2. Agency for Health Care Policy and Research. Evaluation of Cervical Cytology. Evidence Report/Technology Assessment 5. Rockville (MD):AHCPR;1999. Publication no. 99-E010.
3. Taylor PT Jr, Andersen WA, Barbar SR, Covell JL., Smith EB, Underwood PB Jr. The screening Papanicolaou smear: Contribution of the endocervical brush. Obstet Gynecol 1987;70:734-8.
4. Martin-Hirsch P, Lilford R, Jarvis G, Kitchener HC, Efficacy of cervical-smear collection devices: A systematic review and meta-analysis. Lancet 1999;354:1763-70.
5. McCord ML, Stovall TG, Merie JL, Summitt RL Jr, Coleman SA, Cervical cytology: A randomized comparison of four sampling methods. Am J Obstet Gynecol 1992;166:1772-7; discussion 1777-9.
6. Monsonego J, Autillo-Touati A, Bergeron C, Dachez R, Liaras J, Saurel J, et al. Liquid-based cytology for primary cervical cancer screening: A multi-centre study. Br J Cancer 2001;84:360-6.
7. Bernstein SJ, Sanchez-Ramos L, Ndubisi B, Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: A metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol 2001;185:308-17.
8. Vassilakos P. Schwartz D, de Marval F, Yousti L, Broquet G, Mathez-Loic F, et al. Biopsy-based comparison of liquid-based, thin-layer preparations to conventional Pap smears. J Reprod Med 2000;45:11-6.
9. Bergeron C, Bishop J, Lemarie A, Cas F, Ayivi J, Huynh B, et al. Accuracy of thin-layer cytology in patients undergoing cervical cone biopsy Acta Cytol 2001;45:519-24.
10. Alasio LM, Alphandery C, Grassi P, Ruggeri M, De Palo G, Pilotti S. Performance of the AutoPap Primary Screening System in the detection of high-risk cases in cervicovaginal smears. Acta Cytol 2001;45:704-8.
11. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
12. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995;76:1888-901.
13. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000;92:397-402.
14. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ, 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
15. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ, 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. J Low Genit Tract Dis 2002:6:127-43.
16. Solomon D, Schiffman M. Tarone R, Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9.
17. Wesley R, Sankaranarayanan R, Mathew B, Chandralekha B, Aysha Beegum A, Amma NS, et al. Evaluation of visual inspection as a screening test for cervical cancer. Br J Cancer 1997:75:436-40.
18. Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright, TC. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer lnst 2000;92:818-25.
19. Stoler MH, Schiffman M. lnterobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-5.
20. Liao SY, Stanbridge EJ, Expression of the MN antigen in cervical Papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 1996;5:549-57.
21. Mittal K, Mesia A, Demopoulos RI, MIB-1 expression is useful in distinguishing dysplasia from atrophy in elderly women. Int J Gynecol Pathol 1999;18:122-4.
22. Keesee SK, Meyer ML, Hutchinson ML, Cibas ES, Sheets EE, Marchese J, et al. Preclinical feasibility study of NMP179, a nuclear matrix protein marker for cervical dysplasia. Acta Cytol 1999;43:1015-22.